← SynDRA
EZUTROMID
SynDRA canonical compound SYN0026947 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | UTRN |
|---|
| Mechanism of action | utrophin enhancer |
|---|
All known targets
Mechanisms of action (all sources)
- UTRN MODULATOR
- Utrophin modulator
- AHR ANTAGONIST
- utrophin enhancer
- UTRN REGULATOR (UPREGULATOR)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CYP1A2
- HDAC6
- ABCB1
- ABCG2
- CYP1A1
- CYP2B6
- CYP2C19
- CYP2C8
- CYP2C9
- CYP2D6
- CYP3A4
- SLCO1B1
- SLCO1B3
Cross-references
Synonyms
- SMT-C1100
- BMN-195
- BMN195
- SMTC-1100
- Utrophin modulators (Duchenne muscular dystrophy)
- VOXC-1100
- Utrophin modulators (Duchennemuscular dystrophy), VASTox
- Utorphin upregulators (Duchenne muscular dystrophy), VASTox/University of Oxford
- Utrophin modulators (Duchenne muscular dystrophy), Summit/BioMarin
- Utropine inducer (Duchenne muscular dystrophy), Summit/BioMarin
- BMN 195
- SMTC 1100
- 5-ethylsulfonyl-NBO
- 5-Ethylsulfonyl-2-naphthalen-2-yl-1,3-benzoxazole
- 5-(Ethylsulfonyl)-2-(2-naphthalenyl)benzoxazole
- Benzoxazole, 5-(ethylsulfonyl)-2-(2-naphthalenyl)-
- 5-(ETHANESULFONYL)-2-(NAPHTHALEN-2-YL)-1,3-BENZOXAZOLE
- ezutromidum
- RefChem:913211
- 5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole
- Ezutromid [INN]
- MFCD30343856
- 5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo(d)oxazole
- 5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo[D] oxazole
- UNII-645R07LF0D
- Ezutromid?
- SMTC1100
- EZUTROMID [WHO-DD]
- SCHEMBL732212
- orb1304213
- SCHEMBL29376738
- SCHEMBL30791155
- SCHEMBL31080435
- GTPL11110
- GLXC-10808
- GLXC-21713
- GLXC-90448
- EX-A2333
- BDBM50519636
Look up EZUTROMID in the interactive SynDRA portal →